Jason Kim
President bij MOLECULAR TEMPLATES, INC.
Vermogen: 14 260 $ op 31-03-2024
Profiel
Jason S.
Kim's career history includes current positions as President, CFO, CAO & Treasurer at Molecular Templates, Inc. and Chief Operating Officer at Molecular Templates OpCo, Inc. He previously worked as Director-Business Development at ImClone LLC from 2003 to 2006, Director-Business & Corporate Development at OSI Pharmaceuticals, Inc. from 2009 to 2011, and as an Associate at Safeguard Scientifics, Inc. and Domain Associates LLC.
Additionally, he served as President & Chief Financial Officer at Molecular Templates, Inc. from 2010 to 2017.
Mr. Kim obtained an undergraduate degree from Wesleyan University and an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-01-2024 | 6 366 ( 0.12% ) | 14 260 $ | 31-03-2024 |
Actieve functies van Jason Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | President | 01-02-2010 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Operating Officer | - |
Eerdere bekende functies van Jason Kim
| Bedrijven | Functie | Einde |
|---|---|---|
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Director of Finance/CFO | 01-08-2017 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2011 |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Corporate Officer/Principal | 01-01-2009 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01-01-2006 |
| SAFEGUARD SCIENTIFICS, INC. | Corporate Officer/Principal | - |
Opleiding van Jason Kim
| Wesleyan University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SAFEGUARD SCIENTIFICS, INC. | Finance |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
